Veristat is proud to have supported the preparation of 75 marketing applications (NDA, BLA, MAA, etc) that are now approved for patients. For these approved products, direct involvement ...
Learn how to strategically migrate and produce clinical trial data outputs in submission-ready format to reduce timelines without sacrificing data quality.
From our years of experience preparing marketing applications, Veristat has learned there are three key tips to planning.
Careful planning and an optimized timeline can shorten the time required to produce effective, consistent marketing application documents.
Learn how to plan and manage the timeline and operational approaches for marketing application planning, mid-stream adaptation, and final submission.
Veristat was brought in to create and manage a full development program for a gene therapy for a very rare inherited disorder. The work involved charting the course in unexplored waters ...
Get the webinar presentation on how, why and when to expand your clinical trial program into the US, including differences between IND and CTA
Webinar Video Replay
Watch the on-demand webinar on how, why and when to expand your clinical trial program into the US, including differences between IND and CTA
Read our June 2021 of edition of our Newsletter, Voyager, which provides insights on the value a Veristat partnership delivers to overcome the regulatory hurdles that arise during ...